Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Short Interest Update

Quantum Genomics Société Anonyme (OTCMKTS:QNNTFGet Free Report) saw a significant decline in short interest in October. As of October 31st, there was short interest totalling 800 shares, a decline of 98.0% from the October 15th total of 39,700 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Quantum Genomics Société Anonyme Stock Performance

QNNTF stock remained flat at $0.10 during trading on Thursday. The business has a 50 day simple moving average of $0.10 and a 200 day simple moving average of $0.10. Quantum Genomics Société Anonyme has a 1-year low of $0.10 and a 1-year high of $0.10.

About Quantum Genomics Société Anonyme

(Get Free Report)

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure.

Further Reading

Receive News & Ratings for Quantum Genomics Société Anonyme Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum Genomics Société Anonyme and related companies with MarketBeat.com's FREE daily email newsletter.